Who owns Spero Therapeutics Inc?
- Ticker: SPRO
- CUSIP Number: 84833t103
Tip: Access positions for across all investors
Analyze quarterly positions in Spero Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Spero Therapeutics stock
Who bought or sold Spero Therapeutics Inc this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Frigate Ventures | 4.2M | $5.0M | 21% | Sep 2023 |
|
Vanguard Group | 1.6M | $2.4M | 6% | Dec 2023 |
|
Atlas Venture Associates IX | 1.4M | $1.6M | 0% | Sep 2023 |
|
ADAR1 Capital Management | 1.1M | $1.6M | 100% | Dec 2023 |
|
Atlas Venture Life Science Advisors | 1.0M | $1.5M | 0% | Dec 2023 |
|
Alphabet | 890k | $1.3M | 0% | Dec 2023 |
|
Murchinson | 863k | $1.0M | 13% | Sep 2023 |
|
Renaissance Technologies | 547k | $662k | -8% | Sep 2023 |
|
BlackRock | 482k | $583k | -8% | Sep 2023 |
|
Novo A/S | 469k | $567k | 0% | Sep 2023 |
|
Ameriprise Financial | 464k | $561k | -1% | Sep 2023 |
|
Geode Capital Management | 413k | $500k | 6% | Sep 2023 |
|
AWM Investment Company | 333k | $490k | 0% | Dec 2023 |
|
Acadian Asset Management | 272k | $327k | 57% | Sep 2023 |
|
OUP Management | 249k | $301k | 0% | Sep 2023 |
|
Millennium Management | 149k | $219k | 24% | Dec 2023 |
|
Bridgeway Capital Management | 135k | $163k | 23% | Sep 2023 |
|
State Street Corporation | 131k | $158k | 18% | Sep 2023 |
|
DAFNA Capital Management | 125k | $184k | 0% | Dec 2023 |
|
Squarepoint Ops | 123k | $181k | -5% | Dec 2023 |
|
Northern Trust | 89k | $108k | 0% | Sep 2023 |
|
XTX Topco | 58k | $71k | -45% | Sep 2023 |
|
Rock Springs Capital Management | 57k | $69k | -91% | Sep 2023 |
|
Group One Trading | 34k | $41k | -63% | Sep 2023 |
|
Citadel Advisors | 32k | $47k | 100% | Dec 2023 |
|
Charles Schwab Investment Management | 29k | $42k | 0% | Dec 2023 |
|
Prudential Financial | 28k | $34k | 16% | Sep 2023 |
|
Mackenzie Financial | 22k | $32k | 25% | Dec 2023 |
|
Susquehanna International | 20k | $24k | -55% | Sep 2023 |
|
Bourgeon Capital Management | 15k | $22k | 0% | Dec 2023 |
|
Two Sigma Securities | 10k | $15k | 100% | Dec 2023 |
|
Dimensional Fund Advisors | 10k | $15k | -15% | Dec 2023 |
|
Yale Capital Corp. | 10k | $12k | 0% | Sep 2023 |
|
Morgan Stanley | 9.0k | $11k | -6% | Sep 2023 |
|
Russell Investments | 6.4k | $9.4k | 0% | Dec 2023 |
|
Bank of America Corporation | 5.8k | $8.5k | -35% | Dec 2023 |
|
Hanson McClain Advisors | 600.00 | $882.000000 | 0% | Dec 2023 |
|
Tower Research Capital | 572.00 | $692.005600 | 1534% | Sep 2023 |
|
Wells Fargo & Company | 533.00 | $784.309500 | 3% | Dec 2023 |
|
Rhumbline Advisers | 458.00 | $672.985200 | 0% | Dec 2023 |
|
UBS Group | 329.00 | $483.991900 | -99% | Dec 2023 |
|
Royal Bank of Canada | 315.00 | $0 | 5% | Dec 2023 |
|
Jpmorgan Chase & Co | 236.00 | $346.990800 | 0% | Dec 2023 |
|
Us Bancorp | 151.00 | $222.000200 | 0% | Dec 2023 |
|
Goss Wealth Management | 100.00 | $121.000000 | 0% | Sep 2023 |
|
Advisor Group Holdings | 97.00 | $142.997400 | 0% | Dec 2023 |
|
PFS Partners | 50.00 | $74.000000 | -80% | Dec 2023 |
|
Bnp Paribas Arbitrage, Snc | 12.00 | $18.000000 | 0% | Dec 2023 |
|
Qube Research & Technologies | 1.00 | $1.000000 | 100% | Sep 2023 |
|
Who sold out of Spero Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Hrt Financial | Sep 2023 | 19k | $22k |
Two Sigma Investments | Sep 2023 | 17k | $21k |
ERn Financial | Sep 2023 | 16k | $19k |
Cullen Frost Bankers | Sep 2023 | 2.0k | $2.4k |
Beaird Harris Wealth Management | Sep 2023 | 202.00 | $245.005800 |
Heritage Wealth Advisors | Sep 2023 | 187.00 | $226.008200 |
FMR | Jun 2023 | 4.00 | $6.000000 |